Cargando…

MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial

BACKGROUND: Spasticity affects 60–80% of people with multiple sclerosis (MS), impacting activity, participation and quality of life. We developed the group delivered spasticity self-management program, “MS Spasticity: Take Control” (STC), with DVDs for education and lower extremity stretching. STC i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hugos, Cinda L., Cameron, Michelle H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541326/
https://www.ncbi.nlm.nih.gov/pubmed/33028236
http://dx.doi.org/10.1186/s12883-020-01902-1
_version_ 1783591384140218368
author Hugos, Cinda L.
Cameron, Michelle H.
author_facet Hugos, Cinda L.
Cameron, Michelle H.
author_sort Hugos, Cinda L.
collection PubMed
description BACKGROUND: Spasticity affects 60–80% of people with multiple sclerosis (MS), impacting activity, participation and quality of life. We developed the group delivered spasticity self-management program, “MS Spasticity: Take Control” (STC), with DVDs for education and lower extremity stretching. STC is based on an international guideline and recommendations from systematic reviews and emphasizes the importance of stretching with specific stretching exercises. Our pilot trial (n = 38) compared STC followed by one month of home stretching practice to unguided use of the National MS Society (NMSS) brochure titled “Stretching for People with MS: An Illustrated Manual,” also followed by one month of home stretching practice. In this pilot trial, STC showed promising effects on the impact of spasticity (MS Spasticity Scale-88) and other self-report and physical performance measures. We will now carry out a fully-powered trial to evaluate the effect of STC compared to a comparably delivered control program on the impact and severity of spasticity in people with MS and self-reported lower extremity spasticity. METHODS: Two hundred-twenty ambulatory adults with MS self-reported spasticity interfering with daily activities will be randomized 1:1 to STC or control, using the same NMSS brochure used in the pilot study, with both programs delivered in groups with trained facilitators. Outcomes are the impact of spasticity with the MS Spasticity Scale-88, the severity of spasticity with the Numeric Rating Scale for Spasticity, other self-report questionnaires, and physical performance walking measures at baseline and one and 6 months after the interventions. DISCUSSION: Stretching is the cornerstone of spasticity management. Stretching takes time and energy every day. Unfortunately, beyond the logical expectation that regular stretching should help prevent muscle shortening and contractures in the presence of spasticity, there is very little data on the effects of stretching on spasticity in people with MS or any other condition. Our pilot trial of STC suggested that education and stretching help reduce the impact of spasticity. To definitively determine if this education and instructional program with daily stretching practice is effective, a fully powered trial with a comparable control intervention and facilitators who did not create STC is needed. Here we report the protocol for this trial. TRIAL REGISTRATION: NCT03166930 May 25, 2017.
format Online
Article
Text
id pubmed-7541326
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75413262020-10-08 MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial Hugos, Cinda L. Cameron, Michelle H. BMC Neurol Study Protocol BACKGROUND: Spasticity affects 60–80% of people with multiple sclerosis (MS), impacting activity, participation and quality of life. We developed the group delivered spasticity self-management program, “MS Spasticity: Take Control” (STC), with DVDs for education and lower extremity stretching. STC is based on an international guideline and recommendations from systematic reviews and emphasizes the importance of stretching with specific stretching exercises. Our pilot trial (n = 38) compared STC followed by one month of home stretching practice to unguided use of the National MS Society (NMSS) brochure titled “Stretching for People with MS: An Illustrated Manual,” also followed by one month of home stretching practice. In this pilot trial, STC showed promising effects on the impact of spasticity (MS Spasticity Scale-88) and other self-report and physical performance measures. We will now carry out a fully-powered trial to evaluate the effect of STC compared to a comparably delivered control program on the impact and severity of spasticity in people with MS and self-reported lower extremity spasticity. METHODS: Two hundred-twenty ambulatory adults with MS self-reported spasticity interfering with daily activities will be randomized 1:1 to STC or control, using the same NMSS brochure used in the pilot study, with both programs delivered in groups with trained facilitators. Outcomes are the impact of spasticity with the MS Spasticity Scale-88, the severity of spasticity with the Numeric Rating Scale for Spasticity, other self-report questionnaires, and physical performance walking measures at baseline and one and 6 months after the interventions. DISCUSSION: Stretching is the cornerstone of spasticity management. Stretching takes time and energy every day. Unfortunately, beyond the logical expectation that regular stretching should help prevent muscle shortening and contractures in the presence of spasticity, there is very little data on the effects of stretching on spasticity in people with MS or any other condition. Our pilot trial of STC suggested that education and stretching help reduce the impact of spasticity. To definitively determine if this education and instructional program with daily stretching practice is effective, a fully powered trial with a comparable control intervention and facilitators who did not create STC is needed. Here we report the protocol for this trial. TRIAL REGISTRATION: NCT03166930 May 25, 2017. BioMed Central 2020-10-07 /pmc/articles/PMC7541326/ /pubmed/33028236 http://dx.doi.org/10.1186/s12883-020-01902-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Hugos, Cinda L.
Cameron, Michelle H.
MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial
title MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial
title_full MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial
title_fullStr MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial
title_full_unstemmed MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial
title_short MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial
title_sort ms spasticity: take control (stc) for ambulatory adults: protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541326/
https://www.ncbi.nlm.nih.gov/pubmed/33028236
http://dx.doi.org/10.1186/s12883-020-01902-1
work_keys_str_mv AT hugoscindal msspasticitytakecontrolstcforambulatoryadultsprotocolforarandomizedcontrolledtrial
AT cameronmichelleh msspasticitytakecontrolstcforambulatoryadultsprotocolforarandomizedcontrolledtrial